Next Article in Journal
Soliton Fractional Charges in Graphene Nanoribbon and Polyacetylene: Similarities and Differences
Next Article in Special Issue
Thermosensitive Nanocomposite Hydrogels for Intravitreal Delivery of Cefuroxime
Previous Article in Journal
Ethanol-Quenching Introduced Oxygen Vacancies in Strontium Titanate Surface and the Enhanced Photocatalytic Activity
Previous Article in Special Issue
Therapeutic Potential of a Combination of Magnesium Hydroxide Nanoparticles and Sericin for Epithelial Corneal Wound Healing
Open AccessFeature PaperReview

Ocular Drug Delivery: A Special Focus on the Thermosensitive Approach

1
Department of Drug Science and Technology, University of Turin, 10125 Turin, Italy
2
NIS Research Centre, University of Turin, 10125 Turin, Italy
3
Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain
4
Department of Chemistry, University of Turin, 10125 Turin, Italy
5
School of Nanoscience and Technology, Shivaji University Kolhapur, Maharashtra 416004, India
*
Authors to whom correspondence should be addressed.
Nanomaterials 2019, 9(6), 884; https://doi.org/10.3390/nano9060884
Received: 21 May 2019 / Revised: 5 June 2019 / Accepted: 10 June 2019 / Published: 14 June 2019
(This article belongs to the Special Issue Advanced Nanosystems for Ophthalmic Administration)
The bioavailability of ophthalmic therapeutics is reduced because of the presence of physiological barriers whose primary function is to hinder the entry of exogenous agents, therefore also decreasing the bioavailability of locally administered drugs. Consequently, repeated ocular administrations are required. Hence, the development of drug delivery systems that ensure suitable drug concentration for prolonged times in different ocular tissues is certainly of great importance. This objective can be partially achieved using thermosensitive drug delivery systems that, owing to their ability of changing their state in response to temperature variations, from room to body temperature, may increase drug bioavailability. In the case of topical instillation, in situ forming gels increase pre-corneal drug residence time as a consequence of their enhanced adhesion to the corneal surface. Otherwise, in the case of intraocular and periocular, i.e., subconjunctival, retrobulbar, peribulbar administration, among others, they have the undoubted advantage of being easily injectable and, owing to their sudden thickening at body temperature, have the ability to form an in situ drug reservoir. As a result, the frequency of administration can be reduced, also favoring the patient’s adhesion to therapy. In the main section of this review, we discuss some of the most common treatment options for ocular diseases, with a special focus on posterior segment treatments, and summarize the most recent improvement deriving from thermosensitive drug delivery strategies. Aside from this, an additional section describes the most widespread in vitro models employed to evaluate the functionality of novel ophthalmic drug delivery systems. View Full-Text
Keywords: posterior segment diseases; ocular drug delivery; hydrogels; nanocomposites; thermosensitive systems; in vitro pharmacokinetic models posterior segment diseases; ocular drug delivery; hydrogels; nanocomposites; thermosensitive systems; in vitro pharmacokinetic models
Show Figures

Figure 1

MDPI and ACS Style

Sapino, S.; Chirio, D.; Peira, E.; Abellán Rubio, E.; Brunella, V.; Jadhav, S.A.; Chindamo, G.; Gallarate, M. Ocular Drug Delivery: A Special Focus on the Thermosensitive Approach. Nanomaterials 2019, 9, 884.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop